Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05700513Phase 2Unknown
Phase 2, randomised, double-blind trial (2 arms), sponsored by Tabriz University of Medical Sciences. Primary endpoint: Fasting Blood Glucose at Day 180. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05700513.